<DOC>
	<DOCNO>NCT02823223</DOCNO>
	<brief_summary>To compare clinical outcome Endoscopic Lung Volume Reduction use Pulmonx Zephyr Endobronchial Valve ( EBV ) vs. Standard Care ( SoC ) treatment heterogeneous emphysema patient control trial design setting .</brief_summary>
	<brief_title>Endobronchial Valve Patients With Heterogeneous Emphysema</brief_title>
	<detailed_description>The aim prospective , randomize , control , one-way crossover study ass compare efficacy Zephyr endobronchial valve vs. Standard Care ( SoC ) patient suffer COPD Heterogeneous Emphysema . Patients follow 6 month randomization . Patients SoC arm crossover EBV treatment arm 6-month visit follow 6 additional months.The primary objective variation FEV1 baseline 3-month follow-up visit . The secondary objective evaluate quality life , exercise capacity , dyspnea ( include BODE index ) change , target lobe volume reduction , well safety outcome .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Consent form sign Heterogeneous emphysema Chest CT Scanner Intact interlobar fissure adjacent target lobe Chest CT collateral ventilation negative target lobe Chartis assessment Post bronchodilator Forced expiratory volume 1 second ( FEV1 ) &lt; 50 % predict Total Lung Capacity &gt; 100 % predict Residual Volume &gt; 150 % predict PaO2 &gt; 45mmHg Post rehabilitation 6 minute walk test &gt; 140m No COPD exacerbation least 6 week Stopped cigarette smoke 3 month Contraindication bronchoscopy Tuberculosis , pleural effusion , clinically significant bronchiectasis Lung carcinoma pulmonary nodule CT scan require Chest CT scan followup Active pulmonary infection Prior lung transplant , LVRS , median sternotomy , bullectomy lobectomy Any extrapulmonary disease compromise survival evaluation within protocol ( severe cardiac disease , severe renal insufficiency , cancerâ€¦ ) Inclusion study assess respiratory treatment Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Endobronchial Valve</keyword>
</DOC>